When should compliance become a dedicated function? Explore how life sciences companies can align expertise with growth, risk, and complexity.
Biotechnology and life sciences companies operate in one of the most heavily regulated and risk-sensitive industries in the world. From clinical trials and patient data management to intellectual property protection and commercialization, organizations face increasing scrutiny from regulators, investors, third parties, and customers. A common question among founders, boards, and investors is: At what stage should a life sciences company establish a dedicated compliance department?
And the questions keep coming: How many employees do I need to work in the department? Can I outsource compliance? Which risk areas do I focus on?
The answers depend not only on company size or revenue, but also on the organization’s risk profile, operational complexity, regulatory exposure, funding stage, strategic objectives, and compliance maturity. Many startups initially assign compliance responsibilities to legal counsel, finance personnel, or operations leaders. As those risks and responsibilities grow, however, a formal compliance function becomes essential to protect enterprise value, meet regulatory obligations, and support sustainable growth.
Life sciences organizations should establish compliance capabilities and assignments across corporate compliance, internal audit, privacy, cybersecurity, quality, and risk management.
This article was originally published Oct. 8, 2026, in Clinical Leader. Access the full article: “Your Company Needs Compliance Expertise – but When and From Whom?”
Contact us
